{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic+Solution+0.01%25", "query": { "intervention": "Bimatoprost Ophthalmic Solution 0.01%" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic+Solution+0.01%25&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T11:20:51.311Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05401357", "title": "Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Test - Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2022-06-29", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2022-08-10", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 9, "location_summary": "Newport Beach, California • Petaluma, California • New Smyrna Beach, Florida + 6 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "New Smyrna Beach", "state": "Florida" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Roswell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05401357" }, { "nct_id": "NCT02419508", "title": "SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension", "type": "DRUG" }, { "name": "Brinz/brim vehicle", "type": "DRUG" }, { "name": "Prostaglandin analogue", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 290, "start_date": "2015-08-07", "completion_date": "2018-02-27", "has_results": true, "last_update_posted_date": "2018-11-15", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02419508" }, { "nct_id": "NCT01253902", "title": "Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost ophthalmic solution 0.01%", "type": "DRUG" }, { "name": "travoprost ophthalmic solution 0.004%", "type": "DRUG" }, { "name": "latanoprost ophthalmic solution 0.005%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 164, "start_date": "2010-12", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2012-11-07", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 1, "location_summary": "Rogers, Arkansas", "locations": [ { "city": "Rogers", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01253902" }, { "nct_id": "NCT01525173", "title": "A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "0.1% brimonidine tartrate ophthalmic solution", "type": "DRUG" }, { "name": "0.01% bimatoprost ophthalmic solution", "type": "DRUG" }, { "name": "0.2% hypromellose lubricant eye drops", "type": "DRUG" }, { "name": "latanoprost 0.005% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 137, "start_date": "2012-01", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2013-12-04", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 1, "location_summary": "Deerfield Beach, Florida", "locations": [ { "city": "Deerfield Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525173" }, { "nct_id": "NCT07661329", "title": "A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Primary Open Angle Glaucoma (POAG)", "Ocular Hypertension (OH)" ], "interventions": [ { "name": "Bimatoprost ophthalmic solution 0.01% YSBP", "type": "DRUG" }, { "name": "bimatoprost ophthalmic solution 0.01% (Lumigan®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "YS Life Science Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2026-06-02", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 14, "location_summary": "Beverly Hills, California • Inglewood, California • Newport Beach, California + 9 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07661329" }, { "nct_id": "NCT04890106", "title": "Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle" ], "interventions": [ { "name": "Test - Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mankind Pharma Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 310, "start_date": "2021-10-02", "completion_date": "2022-08-11", "has_results": false, "last_update_posted_date": "2022-12-13", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 9, "location_summary": "Bakersfield, California • Mission Hills, California • Newport Beach, California + 5 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04890106" }, { "nct_id": "NCT01927406", "title": "The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Thyroid Eye Disease", "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "Prostaglandin Analog", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2014-06", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2018-05-15", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01927406" }, { "nct_id": "NCT06267274", "title": "A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost Ophthalmic Solution, 0.01%", "type": "DRUG" }, { "name": "LUMIGAN® (bimatoprost ophthalmic solution) 0.01%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2024-04-01", "completion_date": "2025-05-01", "has_results": false, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 4, "location_summary": "Bakersfield, California • Newport Beach, California • Morrow, Georgia + 1 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06267274" }, { "nct_id": "NCT05729594", "title": "Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Bimatoprost Ophthalmic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Laboratoires Thea", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2023-02-27", "completion_date": "2023-04-05", "has_results": false, "last_update_posted_date": "2023-11-14", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 1, "location_summary": "Newark, New Jersey", "locations": [ { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05729594" }, { "nct_id": "NCT00651859", "title": "Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Bimatoprost 0.03% Ophthalmic Solution", "type": "DRUG" }, { "name": "Bimatoprost Vehicle Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": null, "sex": "ALL", "summary": "20 Years and older" }, "enrollment_count": 111, "start_date": "2002-11", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2008-04-03", "last_synced_at": "2026-09-29T11:20:51.311Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00651859" } ] }